Kerr Douglas
CIK 0001814189
Chief Medical Officer
Filings
18
Latest May 14, 2026
Issuers covered
2
Showing
18 of 18
Page 1
Track record
6 of 7 open-market trades scored (86% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 83% | +13.1% | +10.6% | +41.5% | -20.7% |
| 90 days | 6 | 33% | -15.9% | -13.7% | +25.0% | -51.7% |
| 180 days | 5 | 20% | -12.0% | -10.3% | +11.3% | -42.9% |
| 365 days | 2 | 0% | -23.3% | -23.3% | -21.8% | -24.8% |
Issuers
Companies where Kerr Douglas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 10 | May 14, 2026 |
| GBIO | Generation Bio Co. | 8 | Jan 31, 2024 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|